Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Burger

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of a once-daily indinavir/ritonavir regimenP W Hugen, D M Burger, H J ter Hofstede, et al.
Thrombosis Research|December 7, 2024
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding complications in the NetherlandsE M Appelman, E S L Martens, D M Burger, et al.
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistatE J Smolders, E P H Colbers, C T M M de Kanter, et al.
British Journal of Cancer|November 4, 2010
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancerI M E Desar, J N H Timmer-Bonte, D M Burger, et al.
International Journal of Antimicrobial Agents|February 11, 2017
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation?E J Smolders, S Pape, C T M M de Kanter, et al.
AIDS (London, England)|November 14, 1998
Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavirD M Burger, P W Hugen, F P Kroon, et al.
Clinical Pharmacokinetics|June 19, 2016
Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive MedicationsE J Smolders, C T M M de Kanter, R J de Knegt, et al.
Pharmacy World & Science : PWS|July 26, 2002
Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfastP W H Hugen, D M Burger, P P Koopmans, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of a once-daily indinavir/ritonavir regimenP W Hugen, D M Burger, H J ter Hofstede, et al.
Thrombosis Research|December 7, 2024
Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding complications in the NetherlandsE M Appelman, E S L Martens, D M Burger, et al.
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 2016
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistatE J Smolders, E P H Colbers, C T M M de Kanter, et al.
British Journal of Cancer|November 4, 2010
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancerI M E Desar, J N H Timmer-Bonte, D M Burger, et al.
International Journal of Antimicrobial Agents|February 11, 2017
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation?E J Smolders, S Pape, C T M M de Kanter, et al.
AIDS (London, England)|November 14, 1998
Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavirD M Burger, P W Hugen, F P Kroon, et al.
Clinical Pharmacokinetics|June 19, 2016
Drug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive MedicationsE J Smolders, C T M M de Kanter, R J de Knegt, et al.
Pharmacy World & Science : PWS|July 26, 2002
Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfastP W H Hugen, D M Burger, P P Koopmans, et al.
Pageof 14